Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 46512-46513 [2017-21399]
Download as PDF
<![CDATA[
ethrower on DSK3G9T082PROD with NOTICES
46512
Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices
listening session is to exchange
information about the public health
importance of hypoglycemia, and
discuss federal efforts to reduce
preventable hypoglycemia from diabetes
medications. The Department of Health
and Human Services invites public and
private professionals, organizations, and
consumer representatives to register to
attend this listening session at https://
health.gov/news/.
DATES: The public listening session will
be held on November 1, 2017, from 9:00
a.m. to 4:00 p.m. EDT.
ADDRESSES: The meeting will only be
accessible by attendance in-person. For
in-person participants, the meeting will
take place in the Hubert H. Humphrey
Building, Room 800, 200 Independence
Ave. SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT:
Ndome Essoka, Health Policy Fellow,
Office of Disease Prevention and Health
Promotion, Office of the Assistant
Secretary for Health, U.S. Department of
Health and Human Services, 1101
Wootton Parkway, Suite LL100,
Rockville, MD 20852, phone: 240–453–
8217, email: ndome.essoka@hhs.gov or
OHQ@hhs.gov (please indicate in the
subject line: Partnering to Prevent
Hypoglycemia).
SUPPLEMENTARY INFORMATION: In
September 2012, in response to
heightened awareness of the
contribution of adverse drug events
(ADEs) to the burden of health carerelated harm and costs, the Office of the
Assistant Secretary for Health (OASH)
marshaled the wide-ranging and diverse
resources of federal partners to form an
extensive interagency partnership, the
Federal Interagency Steering Committee
and Workgroups for Adverse Drug
Events, whose goals would be to
develop the ADE Action Plan, as well as
identify measures to track national
progress in reducing ADEs and targets to
meet based on those measures.
ODPHP, in conjunction with the
Federal Interagency Steering Committee
and three Federal Interagency
Workgroups, developed and released
the final ADE Action Plan in 2014. The
ADE Action Plan seeks to engage all
stakeholders in coordinated efforts to
reduce ADEs that are not only clinically
significant but largely preventable.
Inpatient and outpatient use of
anticoagulants, diabetes agents, and
opioid analgesics (with specific focus on
ADEs from therapeutic use of opioids)
contribute to the reason why ADEs
account for the greatest number of
measurable harms. The ADE Action
Plan identifies the federal government’s
highest priority strategies and
opportunities for advancement, which
VerDate Sep<11>2014
19:52 Oct 04, 2017
Jkt 244001
will have the greatest impact on
reducing ADEs. Implementation of these
strategies is expected to result in safer
and higher quality health care services,
reduced health care costs, informed and
engaged consumers and, ultimately,
improved health outcomes. For more
information on the ADE Action Plan,
visit https://health.gov/hcq/ade-actionplan.asp.
Purpose of the Meeting: ODPHP is
hosting a listening session titled,
‘‘Reducing Preventable Hypoglycemia.’’
The purpose of this listening session is
to exchange information about the
public health importance of
hypoglycemia, and discuss federal
efforts to reduce preventable
hypoglycemia from diabetes
medications. This information may
assist ODPHP and federal partners in
identifying how patients and providers
are affected by hypoglycemia, where
gaps in knowledge exist, and how
information can be better disseminated.
Meeting Registration: There is no
registration fee to attend the public
listening session. Early registration is
recommended because seating is
limited, and registration will be on a
first-come, first-served basis. There will
be no onsite registration. Persons
interested in attending this listening
session must register online at https://
health.gov/news/. For those without
Internet access, please contact Ndome
Essoka (see FOR FURTHER INFORMATION
CONTACT) to register. If you need special
accommodations due to a disability,
please contact Ndome Essoka at least
seven days in advance.
Dated: September 29, 2017.
Don Wright,
Deputy Assistant Secretary for Health
(Disease Prevention and Health Promotion).
[FR Doc. 2017–21503 Filed 10–4–17; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Council on Alzheimer’s
Research, Care, and Services; Meeting
Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
public meeting of the Advisory Council
on Alzheimer’s Research, Care, and
Services (Advisory Council). The
Advisory Council on Alzheimer’s
Research, Care, and Services provides
advice on how to prevent or reduce the
burden of Alzheimer’s disease and
related dementias on people with the
disease and their caregivers. During the
SUMMARY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
October meeting, the Advisory Council
will welcome its new members and
invite them to share their experiences
and where they see the Council going
over the length of their terms. The
Advisory Council will also spend some
time discussing the process of
developing recommendations and how
those recommendations relate to the
National Plan. The Council will then
spend much of the meeting discussing
the National Research Summit on Care,
Services, and Supports for Persons with
Dementia and Their Caregivers, held on
October 16–17.
DATES: The meeting will be held on
October 27, 2017 from 9:00 a.m. to 5:00
p.m. EDT.
ADDRESSES: The meeting will be held in
Room 800 in the Hubert H. Humphrey
Building, 200 Independence Avenue
SW., Washington, DC 20201.
Comments: Time is allocated in the
afternoon on the agenda to hear public
comments. The time for oral comments
will be limited to two (2) minutes per
individual. In lieu of oral comments,
formal written comments may be
submitted for the record to Rohini
Khillan, OASPE, 200 Independence
Avenue SW., Room 424E, Washington,
DC 20201. Comments may also be sent
to napa@hhs.gov. Those submitting
written comments should identify
themselves and any relevant
organizational affiliations.
FOR FURTHER INFORMATION CONTACT:
Rohini Khillan (202) 690–5932,
rohini.khillan@hhs.gov. Note: Seating
may be limited. Those wishing to attend
the meeting must send an email to
napa@hhs.gov and put ‘‘October 27
Meeting Attendance’’ in the Subject line
by Tuesday, October 17, so that their
names may be put on a list of expected
attendees and forwarded to the security
officers at the Department of Health and
Human Services. Any interested
member of the public who is a non-U.S.
citizen should include this information
at the time of registration to ensure that
the appropriate security procedure to
gain entry to the building is carried out.
Although the meeting is open to the
public, procedures governing security
and the entrance to Federal buildings
may change without notice. If you wish
to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)).
Topics of the Meeting: During the
October meeting, the Advisory Council
will welcome its new members and
invite them to share their experiences
E:\FR\FM\05OCN1.SGM
05OCN1
Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices
and where they see the Council going
over the length of their terms. The
Advisory Council will also spend some
time discussing the process of
developing recommendations and how
those recommendations relate to the
National Plan. The Council will then
spend much of the meeting discussing
the National Research Summit on Care,
Services, and Supports for Persons with
Dementia and Their Caregivers, held on
October 16–17.
Procedure and Agenda: This meeting
is open to the public. Please allow 30
minutes to go through security and walk
to the meeting room. The meeting will
also be webcast at www.hhs.gov/live.
Authority: 42 U.S.C. 11225; Section
2(e)(3) of the National Alzheimer’s
Project Act. The panel is governed by
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which
sets forth standards for the formation
and use of advisory committees.
Dated: September 22, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2017–21399 Filed 10–4–17; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Advisory
Committee on Minority Health
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS), Office of
Minority Health (OMH), is seeking
nominations of qualified candidates to
be considered for appointment as a
member of the Advisory Committee on
Minority Health (hereafter referred to as
the ‘‘Committee or ACMH’’). In
accordance with Public Law 105–392,
the Committee provides advice to the
Deputy Assistant Secretary for Minority
Health on improving the health of racial
and ethnic minority groups, and on the
development of goals and specific
program activities of OMH designed to
improve the health status and outcomes
of racial and ethnic minorities.
Nominations of qualified candidates are
being sought to fill vacancies on the
Committee.
ethrower on DSK3G9T082PROD with NOTICES
SUMMARY:
Nominations for membership on
the Committee must be received no later
than 5:00 p.m. EST on January 3, 2018,
at the address listed below.
DATES:
VerDate Sep<11>2014
19:52 Oct 04, 2017
Jkt 244001
All nominations should be
mailed to Dr. Minh Wendt, Designated
Federal Officer, Advisory Committee on
Minority Health, Office of Minority
Health, Department of Health and
Human Services, 1101 Wootton
Parkway, Suite 600, Rockville, MD
20852.
ADDRESSES:
Dr.
Minh Wendt, Designated Federal
Officer, Advisory Committee on
Minority Health, Office of Minority
Health, Department of Health and
Human Services, Tower Building, 1101
Wootton Parkway, Suite 600, Rockville,
Maryland 20852. Phone: 240–453–8222;
fax: 240–453–8223.
A copy of the ACMH charter and list
of the current membership can be
obtained by contacting Dr. Wendt or by
accessing the Web site managed by
OMH at www.minorityhealth.hhs.gov.
Information about ACMH activities can
be found on the OMH Web site under
the heading About OMH.
SUPPLEMENTARY INFORMATION: Pursuant
to Public Law 105–392, the Secretary of
Health and Human Services established
the ACMH. The Committee provides
advice to the Deputy Assistant Secretary
for Minority Health in carrying out the
duties stipulated under Public Law 105–
392. This includes providing advice on
improving the health of racial and
ethnic minority populations and in the
development of goals and specific
program activities of OMH, which are
to:
(1) Establish short-range and longrange goals and objectives and
coordinate all other activities within the
Public Health Service that relate to
disease prevention, health promotion,
service delivery, and research impacting
racial and ethnic minority populations;
(2) Enter into interagency agreements
with other agencies of the Public Health
Service;
(3) Support research, demonstrations,
and evaluations to test new and
innovative models;
(4) Increase knowledge and
understanding of health risk factors;
(5) Develop mechanisms that support
better information dissemination,
education, prevention, and service
delivery to individuals from
disadvantaged backgrounds, including
individuals who are members of racial
or ethnic minority groups;
(6) Ensure that the National Center for
Health Statistics collects data on the
health status of each minority group;
(7) Enter into contracts with public
and non-profit private providers of
primary health services for the purpose
of increasing the access of individuals
who lack proficiency in speaking the
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
46513
English language by developing and
carrying out programs to provide
bilingual or interpretive services;
(8) Support a national minority health
resource center which provides
resources to the public such as
information services and assistance in
capacity building;
(9) Carry out programs to improve
access to health care services for
individuals with limited proficiency in
speaking the English language; and
(10) Advise in matters related to the
development, implementation, and
evaluation of health professions
education in decreasing disparities in
health care outcomes, including cultural
competency as a method of eliminating
health disparities.
Management and support services for
the ACMH are provided by OMH.
Nominations: The Committee is
composed of 12 voting members. The
Committee composition also can
include non-voting ex officio members.
This announcement is seeking
nominations for voting members. Voting
members of the Committee are
appointed by the Secretary from
individuals who are not officers or
employees of the federal government
and who have expertise regarding issues
of minority health. To qualify for
consideration of appointment to the
Committee, an individual must possess
demonstrated experience and expertise
working on issues impacting the health
of racial and ethnic minority
populations. The Committee charter
stipulates that the racial and ethnic
minority groups shall be equally
represented on the Committee
membership. ACMH is comprised of
members who represent the health
interest of Hispanics/Latinos; Blacks/
African Americans; American Indians
and Alaska Natives; and/or Asian
Americans, Native Hawaiians, and other
Pacific Islanders.
There are a total of four impending
vacancies on the Committee: Three
vacancies on the ACMH that impact the
representation for the health interests of
Hispanics/Latinos and one vacancy that
impacts the representation of Asian
Americans, Native Hawaiians, and other
Pacific Islanders. OMH is particularly
seeking nominations for individuals
who can represent the health interests of
these racial and ethnic minority groups.
Nominations that are received for
individuals to represent other racial and
ethnic minority groups also will be
accepted. These applications will be
retained in files that are maintained by
OMH on potential candidates to be
considered for the ACMH.
Professional/Technical Expertise:
Nominees must have expertise in issues
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 82, Number 192 (Thursday, October 5, 2017)]
[Notices]
[Pages 46512-46513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21399]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Advisory Council on Alzheimer's Research, Care, and Services;
Meeting
AGENCY: Assistant Secretary for Planning and Evaluation, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the public meeting of the Advisory
Council on Alzheimer's Research, Care, and Services (Advisory Council).
The Advisory Council on Alzheimer's Research, Care, and Services
provides advice on how to prevent or reduce the burden of Alzheimer's
disease and related dementias on people with the disease and their
caregivers. During the October meeting, the Advisory Council will
welcome its new members and invite them to share their experiences and
where they see the Council going over the length of their terms. The
Advisory Council will also spend some time discussing the process of
developing recommendations and how those recommendations relate to the
National Plan. The Council will then spend much of the meeting
discussing the National Research Summit on Care, Services, and Supports
for Persons with Dementia and Their Caregivers, held on October 16-17.
DATES: The meeting will be held on October 27, 2017 from 9:00 a.m. to
5:00 p.m. EDT.
ADDRESSES: The meeting will be held in Room 800 in the Hubert H.
Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201.
Comments: Time is allocated in the afternoon on the agenda to hear
public comments. The time for oral comments will be limited to two (2)
minutes per individual. In lieu of oral comments, formal written
comments may be submitted for the record to Rohini Khillan, OASPE, 200
Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may
also be sent to napa@hhs.gov. Those submitting written comments should
identify themselves and any relevant organizational affiliations.
FOR FURTHER INFORMATION CONTACT: Rohini Khillan (202) 690-5932,
rohini.khillan@hhs.gov. Note: Seating may be limited. Those wishing to
attend the meeting must send an email to napa@hhs.gov and put ``October
27 Meeting Attendance'' in the Subject line by Tuesday, October 17, so
that their names may be put on a list of expected attendees and
forwarded to the security officers at the Department of Health and
Human Services. Any interested member of the public who is a non-U.S.
citizen should include this information at the time of registration to
ensure that the appropriate security procedure to gain entry to the
building is carried out. Although the meeting is open to the public,
procedures governing security and the entrance to Federal buildings may
change without notice. If you wish to make a public comment, you must
note that within your email.
SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and
(a)(2)).
Topics of the Meeting: During the October meeting, the Advisory
Council will welcome its new members and invite them to share their
experiences
[[Page 46513]]
and where they see the Council going over the length of their terms.
The Advisory Council will also spend some time discussing the process
of developing recommendations and how those recommendations relate to
the National Plan. The Council will then spend much of the meeting
discussing the National Research Summit on Care, Services, and Supports
for Persons with Dementia and Their Caregivers, held on October 16-17.
Procedure and Agenda: This meeting is open to the public. Please
allow 30 minutes to go through security and walk to the meeting room.
The meeting will also be webcast at www.hhs.gov/live.
Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National
Alzheimer's Project Act. The panel is governed by provisions of Public
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of advisory committees.
Dated: September 22, 2017.
John R. Graham,
Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2017-21399 Filed 10-4-17; 8:45 am]
BILLING CODE 4150-05-P
